208 related articles for article (PubMed ID: 11074903)
1. Methylene blue improves the hepatopulmonary syndrome.
Schenk P; Madl C; Rezaie-Majd S; Lehr S; Müller C
Ann Intern Med; 2000 Nov; 133(9):701-6. PubMed ID: 11074903
[TBL] [Abstract][Full Text] [Related]
2. [Hepatopulmonary syndrome].
Thevenot T; Pastor CM; Cervoni JP; Jacquelinet C; Nguyen-Khac E; Richou C; Heyd B; Vanlemmens C; Mantion G; Di Martino V; Cadranel J
Gastroenterol Clin Biol; 2009; 33(6-7):565-79. PubMed ID: 19481392
[TBL] [Abstract][Full Text] [Related]
3. Blockade of the action of nitric oxide in human septic shock increases systemic vascular resistance and has detrimental effects on pulmonary function after a short infusion of methylene blue.
Weingartner R; Oliveira E; Oliveira ES; Sant'Anna UL; Oliveira RP; Azambuja LA; Friedman G
Braz J Med Biol Res; 1999 Dec; 32(12):1505-13. PubMed ID: 10585632
[TBL] [Abstract][Full Text] [Related]
4. Methylene blue and cirrhosis: pathophysiologic insights, therapeutic dilemmas.
Fallon MB
Ann Intern Med; 2000 Nov; 133(9):738-40. PubMed ID: 11074907
[No Abstract] [Full Text] [Related]
5. Short-term effects of methylene blue on hemodynamics and gas exchange in humans with septic shock.
Gachot B; Bedos JP; Veber B; Wolff M; Regnier B
Intensive Care Med; 1995 Dec; 21(12):1027-31. PubMed ID: 8750129
[TBL] [Abstract][Full Text] [Related]
6. Methylene blue administration in septic shock: a clinical trial.
Preiser JC; Lejeune P; Roman A; Carlier E; De Backer D; Leeman M; Kahn RJ; Vincent JL
Crit Care Med; 1995 Feb; 23(2):259-64. PubMed ID: 7532559
[TBL] [Abstract][Full Text] [Related]
7. Methylene blue used as a bridge to liver transplantation postoperative recovery: a case report.
Roma J; Balbi E; Pacheco-Moreira L; Gonzalez AC; Leal CG; Pousa F; Zynger I; Leite D; Halpern M; Guerra PP; Covelo M; Carius L; Agoglia L; Oliveira A; Enne M
Transplant Proc; 2010 Mar; 42(2):601-4. PubMed ID: 20304203
[TBL] [Abstract][Full Text] [Related]
8. Does methylene blue administration to septic shock patients affect vascular permeability and blood volume?
Donati A; Conti G; Loggi S; Münch C; Coltrinari R; Pelaia P; Pietropaoli P; Preiser JC
Crit Care Med; 2002 Oct; 30(10):2271-7. PubMed ID: 12394955
[TBL] [Abstract][Full Text] [Related]
9. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
10. Right ventricular response to high-dose almitrine infusion in patients with severe hypoxemia related to acute respiratory distress syndrome.
Michard F; Wolff MA; Herman B; Wysocki M
Crit Care Med; 2001 Jan; 29(1):32-6. PubMed ID: 11176154
[TBL] [Abstract][Full Text] [Related]
11. Methylene blue increases myocardial function in septic shock.
Daemen-Gubbels CR; Groeneveld PH; Groeneveld AB; van Kamp GJ; Bronsveld W; Thijs LG
Crit Care Med; 1995 Aug; 23(8):1363-70. PubMed ID: 7634806
[TBL] [Abstract][Full Text] [Related]
12. Deleterious effect of nitric oxide inhibition in chronic hepatopulmonary syndrome.
Almeida JA; Riordan SM; Liu J; Galhenage S; Kim R; Bihari D; Wegner EA; Cranney GB; Thomas PS
Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):341-6. PubMed ID: 17353701
[TBL] [Abstract][Full Text] [Related]
13. The effect of methylene blue on the hemodynamic changes during ischemia reperfusion injury in orthotopic liver transplantation.
Koelzow H; Gedney JA; Baumann J; Snook NJ; Bellamy MC
Anesth Analg; 2002 Apr; 94(4):824-9, table of contents. PubMed ID: 11916779
[TBL] [Abstract][Full Text] [Related]
14. Methylene blue improves the hepatopulmonary syndrome.
Groneberg DA; Fischer A
Ann Intern Med; 2001 Sep; 135(5):380-1. PubMed ID: 11529704
[No Abstract] [Full Text] [Related]
15. Effects of methylene blue on oxygen availability and regional blood flow during endotoxic shock.
Zhang H; Rogiers P; Preiser JC; Spapen H; Manikis P; Metz G; Vincent JL
Crit Care Med; 1995 Oct; 23(10):1711-21. PubMed ID: 7587237
[TBL] [Abstract][Full Text] [Related]
16. Effect of L-NAME, an inhibitor of nitric oxide synthesis, on cardiopulmonary function in human septic shock.
Avontuur JA; Tutein Nolthenius RP; Buijk SL; Kanhai KJ; Bruining HA
Chest; 1998 Jun; 113(6):1640-6. PubMed ID: 9631805
[TBL] [Abstract][Full Text] [Related]
17. The effect of liver transplantation on circulating levels of estradiol and progesterone in male patients: parallelism with hepatopulmonary syndrome and systemic hyperdynamic circulation improvement.
Aller R; de Luis DA; Moreira V; Boixeda D; Moya JL; Fernandez-Rodriguez CM; San Román AL; Avila S; Bárcena R
J Endocrinol Invest; 2001; 24(7):503-9. PubMed ID: 11508784
[TBL] [Abstract][Full Text] [Related]
18. Cardiopulmonary effects of nitric oxide inhalation and methylene blue injection in hepatopulmonary syndrome.
Jounieaux V; Leleu O; Mayeux I
Intensive Care Med; 2001 Jun; 27(6):1103-4. PubMed ID: 11497151
[No Abstract] [Full Text] [Related]
19. Pulmonary hypertension following hepatopulmonary syndrome in a patient with cirrhosis.
Mal H; Burgière O; Durand F; Fartoukh M; Cohen-Solal A; Fournier M
J Hepatol; 1999 Aug; 31(2):360-4. PubMed ID: 10453952
[TBL] [Abstract][Full Text] [Related]
20. Extracorporeal membrane oxygenation rescue therapy in a case of portopulmonary hypertension during liver transplantation: a case report.
Stratta C; Lavezzo B; Ballaris MA; Panio A; Crucitti M; Andruetto P; Fanelli V; Grosso Marra W; Ranieri MV; Salizzoni M
Transplant Proc; 2013 Sep; 45(7):2774-5. PubMed ID: 24034045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
